﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Tabriz University of Medical Sciences</PublisherName>
      <JournalTitle>Journal of Research in Clinical Medicine</JournalTitle>
      <Issn>2717-0616</Issn>
      <Volume>11</Volume>
      <Issue>1</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2023</Year>
        <Month>01</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>The changing profile of neonatal pathogens and susceptibility pattern: prospective observational study from a tertiary center in South India</ArticleTitle>
    <FirstPage>26</FirstPage>
    <LastPage>26</LastPage>
    <ELocationID EIdType="doi">10.34172/jrcm.2023.32177</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Krishnan</FirstName>
        <LastName>Chakkiyar</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-6913-6692</Identifier>
      </Author>
      <Author>
        <FirstName>Gireeshan Veluthedath</FirstName>
        <LastName>Kuzhiyil</LastName>
      </Author>
      <Author>
        <FirstName>Maya</FirstName>
        <LastName>Sudhakaran</LastName>
      </Author>
      <Author>
        <FirstName>Shameem Anathan</FirstName>
        <LastName>Mohammed</LastName>
      </Author>
      <Author>
        <FirstName>Nabeel Valappil</FirstName>
        <LastName>Faisal</LastName>
      </Author>
      <Author>
        <FirstName>Mohandas</FirstName>
        <LastName>Nair</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/jrcm.2023.32177</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2021</Year>
        <Month>11</Month>
        <Day>22</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2023</Year>
        <Month>03</Month>
        <Day>17</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Changing the pattern of neonatal pathogens poses challenges to the management of neonatal sepsis. Profile and antimicrobial susceptibility of neonatal pathogens were evaluated in this prospective observational study in a tertiary center. Methods: Neonates with risk factors and clinical features of sepsis were screened. Blood culture performed in positive-screen babies. Antimicrobial susceptibility was also evaluated. Statistical significance was tested by the chi-square test and t test accordingly. Univariate analysis was performed to study possible correlations in this regard. Results: Out of 431 suspected cases, 89 neonates (20.65%) had sepsis. The rate of early and late-onset sepsis (LOS) was 48.3% and 51.7%, respectively. The clinical spectrum included septicemia 68 (76.5%), congenital pneumonia 13 (14.7%), meningitis 5 (5.7%), and septic arthritis 3 (3.4%), respectively. Gram-positive bacteria constituted 61 (68.5%), while gram-negative was 28 (31.5%) (P&lt;0.05). Staphylococcus aureus (23.6%) and methicillin-resistant S. aureus (MRSA) (22.5%) were the most common isolates. Acinetobacter (15.8%), coagulase-negative staphylococcus areus (CoNS) (11%), Klebsiella (7.9%), enterococci (8%), E. coli (4.5%), and ß hemolytic streptococci (1 case) were other detected pathogens. MRSA, Acinetobacter, and coagulase-negative S. aureus as a single entity involved in sepsis pathogenesis (50.6%) showed a positive correlation with inborn babies, pre-term, low birth weight, and early-onset sepsis (OR; 95% CI: 2.20; 0.94–5.20, 1.82; 0.79–4.22, 1.25; 0.55–2.89 and 1.05; 0.46–2.50 respectively). Susceptibility pattern was penicillin (12.3%), ampicillin (6.7%), cloxacillin (42.9%), cefotaxime (8%), cefazolin (37.9%), cefoperazone sulbactam (81.5%), piperacillin-tazobactam (68.9%), gentamicin (63.5%), amikacin (47.9%), vancomycin (88.9%), linezolid (88.6%), co-trimoxazole (55.4%), and clindamycin (50%). Conclusion: Gram-positive pathogens and opportunistic pathogens like Acinetobacter predominate over the conventional gram-negative pathogens in neonates. Of note, penicillin, ampicillin, and cefotaxime are not suitable for the empiric treatment of neonatal sepsis. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Neonatal sepsis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Gram-positive</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">MRSA</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Acinetobacter</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Antibiotic susceptibility</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Empiric treatment</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>